Treatment of lipid disorders Flashcards

1
Q

What is dislipidemia

A

A disorder of lipoprotein metabolism, including
lipoprotein overproduction or deficiency
Increased: total cholesterol/LDL/TG
Decreased: HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the sources of cholesterol

A

Diet (exogenous)
Liver (endogenous)
Hepatobilliary circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Examples of bile acid binding resins

A

colestyramine
colestipol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the action of bile acid binding resins

A

Cholesterol is converted into bile acids in the liver and enters the bile ducts
resins bind to the BA and allow excretion as faeces instead of returning to the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do bile acid binding resins reduce lipids

A

decrease cholesterol absorption and enterohepatic circulation of BA/cholesterol in hepatocytes
increases LDLr expression and removal of LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the adverse drug reactions of bile acid binding resins

A
  • Constipation
  • Reduced absorption of other medicines
  • Fat-soluble vitamin deficiency
  • Increased triglyceride levels
  • Avoid in bowel or biliary obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the action of ezetimibe

A

Blocks transport protein NPC1L1 in brush border of n enterocytes
inhibits chylomicron (dietary and billiary cholesterol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why are ezetimibes better than bile acid binding resins

A

-does not affect transport of fat-soluble vitamins /TGs/bile acids
-more potent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does ezetimibe reduce lipids

A

-decrease cholesterol absorption
-increase LDL r expression
-decreases LDL in circulation/small HDL increase
Ezetimibe and its active metabolite circulate enterohepatically - Delivers agent back to the site of action - Limits
systemic exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the adverse drug reactions of ezetimibe

A
  • GI disturbance
  • Headache
  • Hepato-biliary disorders (rare)
  • Increased risk of rhabdomyolysis if used with a statin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is an example of fibrates

A

fenofibrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the action of fibrates

A

agonists at PPARa receptor
increases LPL expression in muscle
increases fatty acid uptake and oxidation in muscle cells
decreases TG
Increases apoAI/apoAII synthesis in hepatocytes
increases plasma HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the adverse drug reactions of fibrates

A
  • GI side-effects most common
  • Myositis-like syndrome
  • Rhabdomyolysis (with statin)
    Avoid: hepato-biliary disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give examples of statins

A

simvastatin
atorvastatin
pravastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the action of statins

A

Inhibit HMG-CoA reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do statins reduce lipids

A

-decreased cholesterol synthesis
-decreased synthesis and secretion of lipoproteins
-increased LDL r expression
-decreased LDL in circulation
-small increase in HDL

17
Q

What are the adverse drug reactions of statins

A
  • GI disturbances, insomnia, rashes
  • Hepato-biliary effects
  • Monitor LFT’s (baseline, within 3 months and at 12 months)
  • Transaminases
  • Myopathy / rhabdomyolysis
  • Advise patients to seek medical advice if develop muscle pain,
    tenderness or weakness

Contra-indications
* Active liver disease
* Pregnancy, breast-feeding

18
Q

What is rhabdomyolysis

A

breakdown of myoglobin in muscle and kidney
causes kidney toxicity

19
Q

What to avoid when taking simvastatin (CYP450 metabolised)

A

Avoid:
– Antibacterials (Clarithromycin, erythromycin)
– Antifungals (Azoles – ketoconazole, itraconazole)
– Grapefruit juice
Do not exceed simvastatin 20mg/day:
– Amiodarone
– Anticoagulants
– Calcium-channel blockers
* Amlodipine
* Diltiazem
* Verapamil
Do not exceed simvastatin 10mg/day:
– Fibrates (bezafibrate or ciprofibrate)

20
Q

What drug is taken by those who cannot tolerate statins/ezetimibe

A

PCSK9 inhibitors
alirocumab (monoclonal antibody for PCSK9)

21
Q

What is the action of PCSK9 inhibitors

A

PCSK9 normally decreases LDL receptor
alirocumab increases LDL receptors

22
Q

How is alirocumab administered

A

subcutaneously every 2 weeks